Clin Osteol 2025; 30(3): 172

Nová éra v léčbě osteoporózy: Terrosa v předplněném peru dostupná i mimo specializovaná osteologická centraAdvertorial

MUDr. Hana Strnadová

Published: September 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Strnadová H. Nová éra v léčbě osteoporózy: Terrosa v předplněném peru dostupná i mimo specializovaná osteologická centra. Clinical Osteology. 2025;30(3):172.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 50 CZK
    will be unlocked 1.9.2026

    References

    1. SPC Terrosa. Dostupné na: SÚKL - Přehled léčiv
    2. Indikační omezení úhrady LP Terrosa. Dostupné na: TERROSA 20MCG/80MCL Injekční roztok v předplněném peru
    3. Leder BZ, Tsai JN, Uihlein AV, et al. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet 2015;386(9999):1147-1155, doi: 10.1016/S0140-6736(15)61120-5. Go to original source...
    4. Cosman F, Wermers RA, Recknor C, et al. Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent. J Clin Endocrinol Metab. 2009;94(10):3772-3780, doi: 10.1210/jc.2008-2719. Go to original source...
    5. Cosman F. Anabolics: first line osteoporosis treatment for patients at high risk of fracture. Columbia U College of Physicians and Surgeons, 2018. Dostupné na: www.panoramaortho.com/wp-content/uploads/2018/10/DrFelicia-Cosman-Anabolics-compressed.pdf

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.